John Haley
Analyst · Raymond James
Thanks, Rich, and good morning, everybody. Before I begin, I just want to thank Aida Sukys for her years of service as our Investor Relations Director. Aida has recently moved into another finance position as our company's new Head of Global Finance Business Operations. And I want to thank Aida for her many contributions, her counsel and her partnership over the last 6 years and for being a great ambassador for Willis Towers Watson. We wish her continued success in her new role. Now we'll review our results for the second quarter of 2018 and the first half of 2018. Just as a reminder, as of January 1, 2018, we adopted the new accounting standard, ASC 606. A detailed description of the impact of ASC 606 will be provided in the Form 10-Q filing, and detailed explanation of how the new standard impacted our performance and the presentation of our financial statements has been provided in our earnings release this morning. I'll report the results first using the prior accounting standard, excluding the impact of the new accounting standard. So based on the prior accounting standard, without the impact of ASC 606, reported revenue for the second quarter was $2 billion, up 4% as compared to the prior year second quarter and up 2% on a constant currency basis and up 3% on an organic basis. Reported revenue included $38 million of positive currency movement. We experienced growth on an organic basis across all of our segments for the quarter. Net income was $89 million or up 117% for the second quarter as compared to the prior year second quarter net income of $41 million. Adjusted EBITDA was $427 million or 21.1% of revenue as compared to the prior year adjusted EBITDA of $387 million or 19.8% of revenue, representing a 10% increase on an adjusted EBITDA basis and 130 basis points in margin improvement. For the quarter, diluted earnings per share were $0.62, and adjusted diluted earnings per share were $1.88. Overall, it was a solid quarter. We grew revenue, earnings per share and had enhanced adjusted EBITDA margin performance. First half of 2018, we're very pleased with our financial results. Based on the prior accounting standard without the impact of ASC 606, reported revenue growth for the first half of 2018 was up 7% as compared to the same period in the prior year and up 3% on a constant currency basis and up 4% on an organic basis. Adjusted EBITDA for the first half of 2018 was $1.3 billion or 27.7% of revenue, an increase from adjusted EBITDA of $1.1 billion or 25.6% of revenue for the same period in the prior year, representing an increase of 210 basis points in adjusted EBITDA margin over the same period in the prior year. Now turning to the results on ASC 606 or the new accounting standard. Reported revenues for the second quarter were $2 billion. Net income for the second quarter was $65 million. Adjusted EBITDA for the second quarter was $392 million or 19.7% of revenue. For the quarter, diluted earnings per share were $0.44, and adjusted diluted earnings per share were $1.70. Before moving on to the segment results, I'd like to provide an update on our three areas of integration, revenue synergies, cost synergies and tax savings. The original merger objectives included decreasing the tax rate from approximately 34% to 25% by the end of 2017 and also realizing $100 million to $125 million in cost savings as we exit 2018. So to start with the tax savings. We surpassed our tax goal in 2016 and 2017, and we continue to be under our goal with an expected 22% to 23% adjusted tax rate for 2018. Turning to the cost savings goal. Since the merger, we've saved almost $152 million on a run rate basis and are targeting $175 million of savings on a run rate basis as we exit 2018, which will exceed our original goal of at least $100 million to $125 million run rate savings. Finally, on revenue synergies in the areas of global health solutions, U.S. mid-market exchange and large market P&C. We've already achieved more than 105% of our three year global health solutions synergy sales goals. Our sales pipeline continues to be strong, and we're glad to say we'll be surpassing our revenue goal. Regarding the mid-market health care marketplace, as we previously mentioned, it's been more difficult to sell versus our original plan, we think due to debates around the Affordable Care Act, which may have delayed our clients' overall decision-making in this area. It's still a bit early to make any conclusion on the mid-market exchange progress this year as the sales season continues into November. But overall, given our cumulative sales through 2017 and the new business pipeline, we believe that we'll be at the lower end of the $100 million to $250 million goal as we exit 2018. Now turning to the P&C synergies. We had merger to date sales of more than $128 million. We anticipate these revenues being recognized over a three year period in most cases. We're happy with the overall traction in acquiring new clients in the large market, but our average sale size has been less than our original projections. We continue to build our pipeline and add to our talent base. We anticipate we'll end 2018 with about $150 million of revenue synergy sales rather than the $200 million original merger goal. While this would be short of our original goal, it's clear that the U.S. large market space provides a significant long-term growth opportunity for Willis Towers Watson. And finally, we see revenue synergies develop between the reinsurance and insurance consulting and technology, or ICT teams. It wasn't the revenue synergy we discussed publicly at the time of the merger, but we recognize these 2 groups have relationships and solutions that complemented one another. We've sold more than $25 million of joint reinsurance broking and consulting projects as these groups have been teaming up and utilizing one another's tools and analytics. Now let's look at each of the segments in more detail. To provide clear comparability with prior periods, all commentary regarding the results of our segments will be based on the prior accounting standard and reflect revenues on a constant currency basis unless specifically stated otherwise. Segment margins are calculated using segment revenues and exclude unallocated corporate costs such as amortization of intangibles, restructuring costs and certain transaction and integration expenses resulting from mergers and acquisitions as well as other items, which we consider noncore to our operating results. The segment results do include discretionary compensation. For the second quarter, revenues grew 2% on a constant currency basis and 3% on an organic basis. We experienced growth in all of our segments this quarter and most of our regions. For the second quarter of 2018, the international region led with 7% organic growth. North America had organic growth of 4%. Western Europe had organic growth of 3%, and Great Britain organic revenues were flat. Without the impact of ASC 606, Human Capital & Benefits, or HCB, had a solid quarter with 1% constant currency revenue growth and 3% organic revenue growth as compared to the prior year's second quarter. HCB has now had growth for the last 6 consecutive quarters. For the first half of the year, on an organic basis, HCB revenue growth was 3%. Across our HCB segment, we had continued momentum in our retirement business with 3% organic growth compared to the prior year second quarter and growth across all regions. North America growth was 3% with increased consulting services around mortality funding assumptions, data services projects and stronger bulk lump-sum work. Great Britain had 6% revenue growth as a result of increased consulting demand for actuarial and risk solutions. International was flat for the quarter. Western Europe's revenues improved, primarily due to the positive impact of the timing of revenue in Germany's pension brokerage businesses and a growing client portfolio across Belgium, Denmark and Switzerland. Health and Benefits revenue increased by 4% as compared to the prior year's second quarter, primarily as a result of strong momentum in the global benefit solutions business as well as increased project work and product sales within the brokerage and advisory business in North America. Our Technology and Administration Solutions, or TAS, revenue increased by 4% as compared to the prior year second quarter due to increased project and call center demand. Talent and Rewards second quarter revenue declined by 4% as compared to the prior year second quarter, primarily due to an increase in -- excuse me, to a decrease in advisory services in North America and Great Britain and lower product revenues. The decline in the product revenues in the quarter was primarily due to timing, and we expect to recover that later in the year. The HCB second quarter revenue was $750 million with an operating margin of 16%, down 90 basis points from the prior year second quarter. Margin in the second quarter was adversely impacted by softness in the Talent and Rewards business and by client investments. For the first half of 2018, operating margin was 28%, an increase of 50 basis points from the prior year. Now turning to the HCB results, including the impact of the new revenue standard. The HCB segment had revenues of $780 million and an operating margin of 19%. Overall, we continue to have a positive outlook for the HCB business in 2018. Now let's look at the Corporate Risk & Broking, or CRB, which had a revenue increase of 2% on both the constant currency and organic basis as compared to the prior year second quarter. CRB has now had 6 consecutive quarters of revenue growth. For the first half of the year, CRB grew 4% organically. North America's revenue grew by 3% in the second quarter with strong construction M&A and cyber activity. And post the 2016 and 2017 restructuring, we've had 4 strong consecutive quarters of growth in North America. For the first half of the year, North America's revenue has grown by 5%. International continued its strong momentum with 6% constant currency growth and 8% organic growth in the quarter, driven primarily by CEEMEA, Asia and Latin America, which had a number of new business wins. Western Europe also had solid growth, primarily led by positive results in France with Affinity program wins and strong new business in risk management and specialties. Likewise, there was growth in Sweden and Iberia. Great Britain had a revenue decline of 3%, driven by weakness in transportation due to less aviation and marine contingent revenue. Partially offsetting this decline was an increase in our financial lines business, which had good new business generation. CRB revenues were $669 million with an operating margin of 13% as compared to a 16% operating margin in the prior year second quarter. The second quarter was generally a seasonally weaker quarter from a margin standpoint due to the low level of renewals for some lines of business. Revenue pressure from Great Britain adversely impacted the margin as did continued investments in technology, cyber and infrastructure. Finally, foreign exchange translation had a 70 basis point unfavorable impact on the segment's margin compared to the prior year second quarter. For the first half of 2018, operating margin was 16%, a decrease of 60 basis points from the prior year. Now turning to the CRB results, including the impact of the new revenue standard. For the quarter, CRB had revenues of $674 million and an operating margin of 14%. We continue to be optimistic about the momentum in our CRB business going forward as we expect revenues to continue to build in the second half of the year. Turning to Investment, Risk & Reinsurance, or IRR. Revenue for the second quarter decreased 1% on a constant currency basis and increased 1% on an organic basis as compared to the prior year second quarter. For the first half of the year, IRR grew 1% on a constant currency basis and 4% organically. As a reminder, the reinsurance line of business represents treaty-based reinsurance with some facultative business produced in wholesale. Bulk of Facultative Reinsurance results are captured in the CRB segment. Reinsurance revenue led the segment with 5% revenue growth, driven by international and specialty as a result of solid renewals and favorable timing. Max Matthiessen grew 3% as a result of an increase in assets under management and new business. Insurance Consulting and Technology grew by 3% as a result of increased consulting projects and software sales. Investment grew 4% as a result of new client implementations, alongside higher performance fees. Wholesale declined by 11%, mainly driven by the timing of revenue that was accelerated into the first quarter of 2018 and less demand in the specialty and program businesses. Underwriting and Capital Management, or UCM, experienced a decline of 6% in constant currency revenue. That's just a result of the divestiture of the U.S programs business in 2017 and the Loan Protector businesses in the first quarter of 2018. UCM organic growth was 3%. The IRR segment had revenues of $379 million compared to $374 million for the prior year second quarter and a 23% operating margin, down 110 basis points from the prior year second quarter. The second quarter 2018 margin was impacted by planned investments in new technology and analytics such as our Innovisk investment; as well as by our foreign exchange translation, which had a 50 basis point unfavorable impact on the segment's margin compared to the prior year second quarter. For the first half of 2018, the operating margin was 36%, an increase of 60 basis points from the prior year. Now turning to the IRR results, including the impact of the new revenue standard. IRR had revenues of $385 million and an operating margin of 23%. Overall, we continue to feel positive about the momentum of the IRR business for 2018. Revenues for the BDA segment increased by 9% from the prior year second quarter. BDA has now had 10 consecutive quarters of revenue growth. For the first half of the year, BDA revenues grew by 9%. Driven by increased enrollments, Individual Marketplace revenue increased by 3%. Group Marketplace and Benefits Outsourcing revenues grew 17% as a result of new client wins and special projects. The BDA segment had revenues of $195 million with a 25% operating margin, up 560 basis points as compared to the prior year second quarter. The expansion in margin was a result of the very strong revenue growth as well as our ability to continue to scale these businesses. For the first half of 2018, operating margin was 23%, an increase of 300 basis points from the prior year. The BDA segment, reflecting the new revenue standard, had revenue of $119 million and an operating margin of negative 26%. The primary driver of the difference is due to the effect of the new revenue accounting standard on the Individual Marketplace. These revenues must now be recognized at the date of placement rather than prorating them starting at their effective date. This means that the revenue typically generated by placements in the 2017 fall enrollment period was recorded as an adjustment to the opening balance of retained earnings as of January 1, 2018. This revenue under the prior standard would have started to be recognized in January 2018 on a prorata basis throughout the year. However, the overall revenue profile should not change materially in 2018 as under the new standard, the revenues generated by the policies placed during the fall of 2018 enrollment season will now be recognized immediately. So this will change the seasonality of the revenue recognition to be higher in the second half of the calendar year. Regarding enrollment. The 2019 sales pipeline continues to look strong in both the mid-market and large market space. We currently have over 20 clients with about 270,000 total lives that have committed for the 2019 enrollment period. The mid-market sales season will not be finalized until early November. The Individual Marketplace exchange enrollment process has been changing somewhat over the recent years. We're seeing enrollment spread more evenly throughout the year due to off-cycle enrollments and agents and a more modest increase in enrollments during the fall enrollment season. We're also currently seeing a number of larger companies that are contemplating off-cycle enrollments in 2019. Our Benefits Delivery & Administration offerings remain fundamental to our business and growth engines of our enterprise strategy. We're optimistic about the long-term growth of this business. So before concluding my remarks, I'd like to provide you with an update regarding the review conducted by the U.K. Competition and Markets Authorities of the investment consulting market. 2 weeks ago, the CMA published its provisional decision report, which did not recommend any structural changes to businesses. The report describes the market as not highly concentrated and states there is no evidence of conflicts of interest that give rise to a competition problem. The CMA did recommend certain industry-wide remedies involving mandatory tendering, enhanced fee disclosure and common standards for reporting performance. We welcome the recommendations set out in the CMA report. We've advocated for stronger regulatory oversight of the investment consulting and fiduciary management market for a number of years, and we look forward to working with the regulatory authorities and the wider industry to ensure that best practice becomes normal practice. We also look forward to continuing to work with the CMA, which will issue its final report by March 2019 at the latest. So to wrap up my comments, I'm very pleased with the first half 2018 results and the overall performance of our underlying business. The results for the first half of 2018 were in line with our expectations, and we believe that we remain well positioned to continue our success in the second half of 2018 and beyond. Likewise, I'm excited to see the progress we've made in building Willis Towers Watson. And I'm proud of the more than 43,000 Willis Towers Watson colleagues around the world, who are focused on their clients' success. I'd like to thank our colleagues for their hard work and for their enthusiasm and support and efforts. And now I'll turn the call over to Mike.